Cboe CA - Delayed Quote CAD
NOVO NORDISK CDR (CAD HEDGED) (NVON.NE)
6.81
+0.08
+(1.19%)
At close: April 25 at 3:59:29 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in DKK | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 9 | 7 | 23 | 22 |
| Avg. Estimate | 77.81B | 79.86B | 346.37B | 403.25B |
| Low Estimate | 76.12B | 75.52B | 330.77B | 353.69B |
| High Estimate | 80.02B | 83.31B | 361.68B | 473.83B |
| Year Ago Sales | 65.35B | 68.06B | 290.4B | 346.37B |
| Sales Growth (year/est) | 19.07% | 17.34% | 19.27% | 16.42% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| NVON.NE | -- | -- | -- | -- |
| S&P 500 | 6.94% | 4.52% | 8.32% | 14.18% |
Related Tickers
NVS.NE NOVARTIS CDR (CAD HEDGED)
21.68
0.00%
ROG.NE Roche Holding AG
20.82
0.00%
MRK.NE Merck & Co., Inc.
19.03
+4.10%
JNJ.NE JOHNSON & JOHNSON CDR (CAD HEDG
20.38
-0.29%
LLY.NE Eli Lilly and Company
32.63
+2.77%
PFE.NE Pfizer Inc.
10.54
+0.38%
BAYRY Bayer Aktiengesellschaft
6.62
+2.48%
NVS Novartis AG
112.14
+0.87%
RHHBY Roche Holding AG
39.52
-0.55%
JNJ Johnson & Johnson
154.58
-0.23%